Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study
Gut and Liver · 2025
DOI: 10.5009/gnl250067 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Gut and Liver, 2025. Verfasst von Jae Yong Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Helicobacter Infections, Helicobacter pylori, Proton Pump Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: HK inno.N Corp..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
- Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
- Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
- Department of Internal Medicine, Digestive Disease Center and Research Institute, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
ORCID-Profile: Jae Yong Park, Il Ju Choi, Gwang Ha Kim, Su Jin Hong, Sung Kwan Shin, Seong Woo Jeon, Jae Gyu Kim
Förderung
- HK inno.N Corp.
Zitieren
APA
Park, J. Y., Choi, I. J., Kim, G. H., Hong, S. J., Shin, S. K., Jeon, S. W., & Kim, J. G. (2025). Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study. Gut and Liver. https://doi.org/10.5009/gnl250067
Vancouver
Park JY, Choi IJ, Kim GH, Hong SJ, Shin SK, Jeon SW, et al. Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study. Gut and Liver. 2025. doi:10.5009/gnl250067
BibTeX
@article{Park2025,
author = {Park, Jae Yong and Choi, Il Ju and Kim, Gwang Ha and Hong, Su Jin and Shin, Sung Kwan and Jeon, Seong Woo and Kim, Jae Gyu},
title = {Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study},
journal = {Gut and Liver},
year = {2025},
doi = {10.5009/gnl250067}
}
EUVIMED